Trius Therapeutics Inc Asset Turnover Ratio (TSRX), as of second quarter 2013, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Trius Therapeutics Inc  (TSRX)
 

Trius Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Trius Therapeutics Inc's asset turnover ratio, the ratio that measures the ability of Trius Therapeutics Inc's assets to generate revenue, sequentially decreased to 0.18 in the second quarter (Jun 30 2013), which does not come as a surprise, as the Trius Therapeutics Inc continue to experience difficult business climate.

Within sector 32 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2013 compared to the preceding quarter from 1016 to 3078.

Asset Turnover Ratio Definition



TSRX Asset Turnover Ratio (Jun 30 2013)
II. Quarter
(Mar 31 2013)
I. Quarter
(Dec 31 2012)
IV. Quarter
(Sep 30 2012)
III. Quarter
(Jun 30 2012)
II. Quarter
Y / Y Asset Change -21.85 % -15.7 % 10.49 % 4.22 % 55.02 %
Y / Y Revenue Change -79.26 % -82.43 % 3.1 % -80.38 % 117.7 %
Asset Turnover Ratio (TTM) 0.18 0.22 0.3 0.31 0.59
TSRX's Total Ranking # 3078 # 1016 # 1016 # 0 # 0
Seq. Asset Change -17.55 % 19.32 % -6.2 % -15.31 % -11.06 %
Seq. Revenue Change -25.25 % -66.51 % -13.68 % -4.03 % -36.7 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 33
Healthcare Sector # 291
Overall Market # 3078

Asset Turnover Ratio Statistics
High Average Low
4.85 4.22 3.84
(Dec 31 2012)   (Jun 30 2013)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2013, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2013 Assets at quarter ending Jun 30 2013
Emergent Biosolutions Inc   0.52 $ 286.734  Millions$ 549.564  Millions
Abbvie Inc   0.52 $ 18,735.000  Millions$ 35,986.698  Millions
Anika Therapeutics Inc   0.52 $ 73.448  Millions$ 141.674  Millions
Guided Therapeutics Inc   0.52 $ 2.094  Millions$ 4.058  Millions
Avid Bioservices Inc   0.51 $ 22.120  Millions$ 43.017  Millions
Immucell Corporation  0.51 $ 5.711  Millions$ 11.122  Millions
Remedent Inc   0.51 $ 3.222  Millions$ 6.312  Millions
Celgene Corp  0.51 $ 5,930.261  Millions$ 11,689.858  Millions
Zimmer Biomet Holdings Inc   0.51 $ 4,514.400  Millions$ 8,909.625  Millions
Vertex Pharmaceuticals Inc  0.50 $ 1,309.118  Millions$ 2,613.669  Millions
Astrotech Corp  0.50 $ 23.995  Millions$ 48.062  Millions
Tandem Diabetes Care Inc   0.50 $ 151.148  Millions$ 303.885  Millions
Orasure Technologies Inc  0.48 $ 89.761  Millions$ 186.186  Millions
Genmark Diagnostics Inc   0.48 $ 31.014  Millions$ 64.342  Millions
Illumina Inc   0.48 $ 1,272.191  Millions$ 2,642.865  Millions
Medtronic Plc  0.48 $ 16,664.000  Millions$ 34,668.750  Millions
Gilead Sciences Inc   0.47 $ 10,313.911  Millions$ 21,759.927  Millions
China Pediatric Pharmaceuticals, Inc.  0.47 $ 4.991  Millions$ 10.645  Millions
Zogenix Inc   0.47 $ 33.872  Millions$ 72.740  Millions
Merrimack Pharmaceuticals Inc  0.46 $ 58.621  Millions$ 126.707  Millions
Ironwood Pharmaceuticals inc   0.46 $ 136.311  Millions$ 296.387  Millions
Halozyme Therapeutics Inc   0.46 $ 53.415  Millions$ 116.741  Millions
Angiodynamics Inc   0.46 $ 346.044  Millions$ 757.046  Millions
Dendreon Corp  0.45 $ 304.373  Millions$ 669.762  Millions
Viropharma Inc  0.45 $ 531.644  Millions$ 1,170.600  Millions
Icu Medical Inc  0.45 $ 317.037  Millions$ 699.826  Millions
Biodelivery Sciences International Inc   0.45 $ 26.112  Millions$ 57.665  Millions
Cryoport inc   0.45 $ 1.397  Millions$ 3.118  Millions
Cumberland Pharmaceuticals Inc   0.45 $ 43.567  Millions$ 97.318  Millions
Bristol myers Squibb Company  0.44 $ 15,806.000  Millions$ 36,037.750  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.